AVROBIO Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page)
POWER OFATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Erik Ostrowski as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Erik OstrowskiErik Ostrowski | President, Interim Chief Executive Officer, Chief Financial Officer, and Treasurer(Principal Executive, Financial, and Accounting Officer) | March 14, 2024 |
| /s/ Bruce BoothBruce Booth, D.Phil. | Chairman of the Board of Directors | March 14, 2024 |
| /s/ Ian T. ClarkIan T. Clark | Director | March 14, 2024 |
| /s/ Gail Farfel, Ph.D.Gail Farfel | Director | March 14, 2024 |
| /s/ Phillip B. DonenbergPhillip B. Donenberg | Director | March 14, 2024 |
| /s/ Annalisa JenkinsAnnalisa Jenkins, M.B.B.S., F.R.C.P | Director | March 14, 2024 |
| /s/ Christopher PaigeChristopher Paige, Ph.D. | Director | March 14, 2024 |
| /s/ Philip J. VickersPhilip J. Vickers, Ph.D. | Director | March 14, 2024 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.